Texas Oncology Fort Worth Cancer Center — Fort Worth, Texas

Texas Oncology Fort Worth Cancer Center is a clinical research site located in Fort Worth, Texas, United States 76104.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology Fort Worth Cancer Center has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma.

Sponsors: Toray Industries, Inc, K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc, BeiGene.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology Fort Worth Cancer Center?

Texas Oncology Fort Worth Cancer Center has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology Fort Worth Cancer Center conducted?

Texas Oncology Fort Worth Cancer Center has 4 clinical trials on record, with 2 currently active. Their work covers Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma.

Is Texas Oncology Fort Worth Cancer Center accredited by Crixeo Health?

Texas Oncology Fort Worth Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology Fort Worth Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.